A cure for HIV: where we've been, and where we're headed

Lancet. 2013 Jun 15;381(9883):2057-8. doi: 10.1016/S0140-6736(13)61180-0.
No abstract available

MeSH terms

  • Anti-Retroviral Agents / therapeutic use
  • Clinical Trials as Topic*
  • Disease Reservoirs
  • Drug Therapy, Combination
  • Global Health
  • HIV Infections / genetics
  • HIV Infections / immunology
  • HIV Infections / therapy*
  • Humans
  • Receptors, CCR5 / genetics
  • Time Factors

Substances

  • Anti-Retroviral Agents
  • Receptors, CCR5